A retrospective study to evaluate whether prolonged administration of bevacizumab leads to brain atrophy in patients with high-grade gliomas.
Phase of Trial: Phase IV
Latest Information Update: 26 Feb 2016
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioblastoma; Glioma
- Focus Adverse reactions
- 26 Feb 2016 New trial record